论文部分内容阅读
目的探讨亚急性肝衰竭人工肝疗效。方法对2008年1月至2010年1月采取人工肝血浆置换联合血液滤过治疗亚急性肝衰竭患者48例临床资料进行总结。结果 48例采取人工肝血浆置换联合血液滤过治疗亚急性肝衰竭患者治愈及好转出院36例,治愈及好转率75.00%,死亡12例,病死率25.00%,不良反应发生率12.5%。结论亚急性肝衰竭患者中应用人工肝血浆置换联合血液滤过治疗临床疗效确切,并发症发生率低,应用方便。
Objective To investigate the effect of artificial liver on subacute liver failure. Methods The clinical data of 48 patients with subacute hepatic failure treated with artificial liver plasma exchange and hemofiltration during January 2008 to January 2010 were summarized. Results In the 48 cases of artificial liver replacement and hemofiltration, 36 cases were cured and discharged after treatment. The cure and improvement rate was 75.00%, 12 cases died, the case fatality rate was 25.00% and the incidence of adverse reactions was 12.5%. Conclusion The clinical effect of artificial liver plasma exchange combined with hemofiltration in patients with subacute hepatic failure is accurate, the incidence of complications is low and the application is convenient.